From licensing, to clinical trials, to competitor activity – you’ll stay up to date on news worldwide thanks to our global team of 60+ journalists. We go beyond headlines too, with access to key decision-makers and best-in-class proprietary data.
How it works
You’ll get business-critical market and company intelligence from our network of analysts, journalists and key opinion leaders. They cover companies from biotech start-ups to multinational giants such as Pfizer, Sanofi and Shire, and fields including cancer, cardiovascular, diabetes, dermatology, influenza and oncology.
How Scrip can help
Understand what’s behind the headlines – we focus on the strategic implications of global pharma news so you can see what developments mean for your business.